📰 Peter Hecht News
Page 3 - Peter Hecht News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Hecht. Real-time updates on events, politics, business and more.
March 27, 2023
CAMBRIDGE, Mass., March 27, 2023 -- Cyclerion Therapeutics, Inc. , a clinical-stage biopharmaceutical company on a mission to develop treatments for serious diseases, today announced that the U.S.... | March 27, 2023
March 27, 2023
The FDA has granted Orphan Drug designation to zagociguat for the treatment of mitochondrial disease.
October 24, 2022
BOSTON, Oct. 24, 2022 /PRNewswire/ -- Ariadne Labs today announced Ambassador Román Macaya, PhD, MBA, as a new member of its Advisory Board. Forme...
October 6, 2022
Recent positive MELAS clinical study data drive urgency to deliver potential first-ever therapy for patients with rare, genetic mitochondrial diseases ...
June 29, 2022
Cyclerion Therapeutics Provides Additional Positive CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation - read this article along with other careers information, tips and advice on BioSpace
June 28, 2022
/PRNewswire/ -- Ariadne Labs today announced John Maraganore, PhD, as a new member of its Advisory Board. In joining the Advisory Board, Dr. Maraganore will...
June 28, 2022
Data for CY6463, a first-in-class, CNS-penetrant, sGC stimulator, demonstrate safety and positive effects across biomarkers of disease in MELAS patients ...
June 22, 2022
Company to discuss positive topline and additional clinical data for CY6463 in MELAS patients Mitochondrial disease clinician-researcher, Amel Karaa,...
June 13, 2022
Philadelphia, PA (PRWEB) June 13, 2022 -- Sports and Entertainment Risk Management Alliance (SERMA) appointed Peter Hecht to the SERMA Advisory Board,
June 1, 2022
Urban water use is latest target for drought cutbacks